资讯

The American Journal of Managed Care21 天
Meta-Analysis Finds SGLT2 Inhibitors Boost Hemoglobin, Hematocrit in CKD
SGLT2 inhibitors significantly improve hemoglobin and hematocrit levels in CKD patients, enhancing anemia management. The KDIGO 2024 guideline endorses SGLT2 inhibitors for CKD patients ...
Renal & Urology News22 天
Thrice-Weekly Vadadustat Noninferior to MPG-EPO in Maintaining Hemoglobin in Dialysis
Target-range hemoglobin levels were maintained over 1 year in patients on dialysis switching from the long-acting ESA to thrice-weekly vadadustat. Vadadustat is noninferior to methoxy polyethylene ...